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There is increasing evidence that a wider range of lymphoid cell types other than CD4 T helper lymphocytes are infected
with HIV-1 in vivo, including CD8 lymphocytes, natural killer cells, and reticulodendritic cells. Each potentially contributes to
the reservoir of infected cells that resist antiviral treatment and to the impairment of immune responses in AIDS. By
quantitative PCR for HIV proviral sequences we have now obtained evidence for substantial infection of  lymphocytes,
contributing 3–45% of the proviral load in peripheral blood. A large proportion of  lymphocytes constitutively expressed the
chemokine receptors CCR5 and CXCR4, with evidence for marked up-regulation of CD8 in samples from HIV-infected
individuals, corresponding to an activated phenotype. That  lymphocytes might be susceptible to HIV infection was
investigated using in vitro infectivity assays of recombinant HIV-expressing green fluorescent protein, followed by flow
cytometry. , CD4, and CD8 lymphocytes were each productively infected, with  lymphocytes showing the greatestdependent. © 2003 Elsevier Science (USA)
INTRODUCTION
Infection with human immunodeficiency virus type 1
(HIV-1) invariably leads to the destruction of CD4 T
helper lymphocytes whose loss contributes to the pro-
found immunodeficiency underlying the development of
clinical AIDS. The tropism of HIV for this cell type results
from its expression of CD4, and the necessary corecep-
tors CXCR4 and/or CCR5 (Klatzmann et al., 1984; Dal-
gleish et al., 1984; Maddon et al., 1986; Feng et al., 1996;
Alkhatib et al., 1996; Dragic et al., 1996), which act as
receptors for the attachment and entry of HIV-1. In prin-
cipal, expression of CD4 and either chemokine receptor
could make other lymphoid and nonlymphoid cell types
susceptible to HIV-1 infection in vivo. For example, com-
bined CD4 and CCR5 expression likely accounts for the
infection of macrophages and macrophage-derived cell
types in vivo. Documenting the extent of infection of
nonlymphoid cell types by HIV-1 is important as their
destruction or functional impairment potentially further
harms the immune system and contributes to the patho-
genesis of AIDS.
We have previously demonstrated infection of both
CD4 and CD8 lymphocytes in peripheral blood mononu-
clear cells (PBMCs) by PCR analysis of highly purified
subsets of lymphocytes isolated by magnetic bead sep-
aration methods (Livingstone et al., 1996; McBreen et al.,2001). Recently we have used a pan-T negative isolation
method to purify T lymphocytes from PBMCs, followed by
positive selection for CD8 and CD4. Quantitation of pro-
viral sequences by limiting PCR indicated substantial
infection of both lymphocyte subsets in the majority of
individuals, although we also detected a significant res-
ervoir of infection in the remaining lymphocytes ( T
lymphocytes and CD3 “nul” cells), in agreement with a
previous study describing infection of null (CD4, CD8)
T lymphocytes with HIV in vivo (Mardon et al., 1999).
Although it possible that the infected cells represent
CD4 lymphocytes with Nef-induced down-regulation of
CD4, it is also possible that HIV infects other classes of
T lymphocytes. Among these, numerically the most
prominent are those expressing the  T cell receptor
(TCR) that differentiate from intrathymic T cell precursors
following rearrangement of the T cell receptor to express
 and  gene segments (reviewed in MacDonald et al.,
2001). These lymphocytes are predominantly distributed
in the gut, lung, and genitourinary tracts and are believed
to play an role in mucosal immunity, in both coordination
of immune reactions through release of cytokines, pri-
marily of the TH1 spectrum, and direct cytolytic effects
particularly against cells infected with intracellular
pathogens such as mycobacteria and parasites. Recog-
nition of pathogens by  T lymphocytes is not MHC
restricted nor limited to antigenic peptides and they do
not require antigen-presenting cells to become activatedsusceptibility. For each cell type, blocking assays with a
1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 44 131 650 6511. E-mail: Peter.Simmonds@ed.ac.uk.
doi:10.1006/viro.2002.1759D4 monoclonal antibody indicated that entry was CD4-
(Pfeffer et al., 1990).  lymphocytes account for between
0.5 and 15% of peripheral blood T lymphocytes, although
0042-6822/03 $30.00n anti-C© 2003 Elsevier Science (USA)
All rights reserved.415
whether they play any functional role in immunity outside
of mucosal tissues is unknown. Frequencies of circulat-
ing  lymphocytes show a modest increase in PBMCs
from HIV-infected individuals (Moreau et al., 1996; Roe-
derer, 2000), and it has been suggested that this repre-
sents a homeostatic mechanism that maintains lympho-
cyte numbers to compensate for destruction of CD4
lymphocytes (Roederer, 2000).
There is limited information on the effect of HIV infec-
tion on  T lymphocyte function, and the contribution of
such damage to the immunodeficiency observed in
AIDS. Increased  T lymphocyte numbers in the gas-
trointestinal epithelium is associated with increasing dis-
ease severity, which may represent increased immune
activation (Nilssen et al., 1996; Norazmi et al., 1995). A
repeated observation is the numeric decline and func-
tional impairment of the  lymphocyte subset express-
ing the V9/V2 receptors (Wallace et al., 1997; Poccia et
al., 1996). These cells have demonstrated cytolytic activ-
ity against cells infected with a range of viruses including
HIV (Sciammas and Bluestone, 1999; Poccia et al., 1999),
although whether infection of  lymphocytes by HIV
underlies the functional impairment and repertoire
changes observed in HIV-infected individuals remains
difficult to assess. The majority of peripheral  T lym-
phocytes are double negative for CD4 and CD8, with
CD4 expression less frequent than CD8 (Hayday, 2000).
CD8 expression has to be reported on activated  T
lymphocytes, although they express the  CD8 ho-
modimer rather than the  CD8 heterodimer found on
 TCR CD8 lymphocytes (Hayday, 2000; Taupin et al.,
1999). Of relevance to HIV pathogenesis is the recent
observation of high frequencies of expression of the
principal coreceptor for HIV, CCR5, on the V2 subset of
 lymphocytes in the peripheral circulation (Glatzel et
al., 2002). Whether the numerical decline of this subset in
HIV infection is associated with reduction in the fre-
quency of CCR5-positive  lymphocytes on the devel-
opment of AIDS is currently unknown.
In this study, we investigated the expression of CD4,
CD8, and the chemokine receptors CCR5 and CXCR4 on
 lymphocytes in the peripheral circulation, as part of a
preliminary assessment of their infectibility by HIV. We
also modified our CD4 and CD8 lymphocyte separation
method to enable the isolation of highly purified  lym-
phocytes from PBMCs to enable their contribution of
proviral load to be quantified. We also investigated pos-
sible genetic differences between variants of HIV-1 iso-
lated from the CD3 CD4 lymphocytes and  lympho-
cytes from four HIV-seropositive individuals that might
determine differences in cellular tropism. Finally, an in
vitro infectivity assay was used to determine if HIV-1 can
replicate in  T lymphocytes and investigate the entry
requirements.
RESULTS
Expression of CD4, CD8, CCR5, and CXCR4 on
peripheral  T lymphocytes
To investigate the surface phenotype of  lympho-
cytes in vivo, and thus their potential susceptibility to HIV
infection, PBMCs from HIV-seronegative and -seroposi-
tive individuals were analysed for expression of CD4,
CD8, CCR5, and CXCR4 by three-colour FACS analysis
with different combinations of monoclonal antibodies
(Mabs). Using Mabs to CD4, CD8, and the  receptor,
CD4 expression was detected on distinct populations of
 lymphocytes at frequencies ranging from 6.97 to
9.57% (mean, 8.14%, n  5) for the seronegative individ-
uals and between 2.06 and 9.25% (mean, 4.44%, n  7)
of  lymphocytes from the seropositive individuals. Ir-
respective of HIV infection, levels of expression of CD4
on positive  lymphocytes were approximately fivefold
lower than found on CD4 T lymphocytes [mean fluores-
cent intensity for  lymphocytes: 28 (range, 12–49),
compared with 140 (range, 99–170) for CD4  TCR
lymphocytes].
The numeric decline in the frequency of CD4 expres-
sion on  lymphocytes in HIV infection contrasted with
the observation of more frequent CD8 expression in this
subset in samples from HIV-infected individuals (mean,
53.41%; range, 28.8–87.47%, n  7), compared with a
mean value of 10.63% for HIV-uninfected individuals
(range, 0.26–17.46%, n  5; Figs. 1A and 1B). Dual
expression of CD4 and CD8 on  lymphocytes was
detected on a small population of cells, with 0.57%
(range, 0.4–1.24%, n  5) from seronegative individuals
and 0.95% (range, 0.52–2.16%, n  7) from seropositive
individuals (Figs. 1A and 1D).
Expression of the chemokine receptors expression on
 lymphocytes was determined by a FACS analysis of
PBMC using a second set of monoclonal antibodies to
CXCR4, CCR5, and the  receptor. The majority (mean,
62.70%, n  5) of  lymphocytes from seronegative
individuals expressed high levels of CCR5 (Figs. 1A and
1C), while lower frequencies of expression were de-
tected in those from seropositive subjects (mean, 31.70%,
n  7; Figs. 1A and 1C). In contrast, while expression of
CXCR4 occurred at a generally low level on a minority of
the  population (mean, 34.75%, n  5; Figs. 1A and 1C)
from seronegative individuals, higher CXCR4 expression
levels were found on the / lymphocytes from infected
individuals (mean 44.53%, n  7, Figs. 1A and 1C).
Combining the results of the two FACS analyses, the
expression of CD4, CCR5, and CXCR4 indicates the po-
tential infectibility of at least a proportion of  lympho-
cytes by HIV.
HIV-1 proviral burden of  lymphocytes in vivo
To investigate the extent of HIV infection of  lympho-
cytes in vivo, , CD4, CD8, and non-T lymphocytes were
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separated from PBMCs from seven HIV-seropositive in-
dividuals, and proviral sequences quantified by limiting
dilution PCR (Simmonds et al., 1990b) using LTR primers
as previously described (Imlach et al., 2001). The purity of
each immunomagnetically isolated subset of lympho-
cytes apart from  lymphocytes was previously as-
sessed (Imlach et al., 2001). The isolation method for 
lymphocytes achieved very high purities of  lympho-
cytes, with between 98.8 and 99.9% (mean, 98.9%, n  3)
of this isolated subset expressing CD3 and the  TCR.
Frequencies of non- lymphocytes were extremely low;
between 0.03 and 0.46% (mean, 0.21%, n  3) of cells
were contaminating CD4 lymphocytes.
All samples of purified  lymphocytes contained de-
tectable proviral sequences using primers from the ini-
tially transcribed region of the LTR that detects all pro-
viral transcripts (pan-LTR) and using those that span the
tRNA binding site, designed to detect completed tran-
scripts only (C-LTR; Table 1). Frequencies of proviral
sequences detected in  lymphocytes ranged from 10 to
500 copies/106 cells, as estimated by limiting dilution
using the pan-LTR primers. Within the accuracy limits of
the assay, proviral loads measured using the pan-LTR
and C-LTR primers were comparable (Table 1, column 3),
indicating that the majority of or all sequences corre-
sponded to complete proviruses. Comparison of proviral
frequencies in  lymphocytes, CD4, CD8, and residual
null cells allowed the contribution of each lymphocyte
population to overall proviral load in PBMCs to be cal-
culated, taking into account their relative frequencies in
the total lymphocyte population (Table 1, Fig. 2).  lym-
phocytes contributed between 3 and 45% of proviral load
in PBMCs as assessed with the C-LTR primers. No
obvious associations between disease progression (as
indicated by CD4 absolute count) with frequency of in-
fection of any of the lymphocyte subsets was apparent.
As described for our previous investigation of CD8
lymphocyte infection (Imlach et al., 2001), we needed to
calculate the frequency of contaminating CD4 lympho-
cytes in the purified  lymphocyte subset to exclude the
former as the source of the proviral sequences. Based on
the purity estimations of the separated  lymphocytes,
“worst case” frequencies of infection ranging from only
0.24 to 4.1 copies/106 cells, or 0.57–2.9% of the proviral
load detected in the  lymphocytes were contributed by
CD4 lymphocytes, based on 0.46% contamination (Table
1). CD4 lymphocyte contamination was therefore not the
source of proviral sequences detected in  lympho-
cytes.
To investigate the genetic relationship between HIV-1
variants from immunomagnetically isolated  lympho-
cytes and CD3 CD4 lymphocytes, phylogenetic analy-
sis was carried out on the V3 hypervariable region of
gp120 amplified from proviral sequences detected in the
two lymphocyte subsets (Fig. 3). From the four HIV se-
ropositive individuals, V3 sequences from  lympho-
cytes and CD3 CD4 lymphocytes were found to be
generally interspersed, indicating that HIV-1 variants in-
fecting the two cell types were genetically similar. To
formally demonstrate the degree of population segrega-
TABLE 1
Frequency of Infection and Contribution to Overall Proviral Load of Immunomagnetically Isolated  Lymphocytes
from HIV Seropositive Individuals
Study
subject
Percentage in
PBMC sample
Frequency/
106 cellsa
Proportion
proviral loadb
Contribution CD4
 TCR cellsc
Proportion CD4
in  subsetd
Pan-LTR
P8 9.4% 200 13% 3.1 1.89%
P10 4.9% 100 8% 2.60 2.88%
P11 1.4% 200 5% 0.99 0.57%
P12 2.4% 500 26% 1.43 0.29%
P13 14.7% 100 14% 2.68 2.66%
P14 7.8% 10 5% 0.13 2.31%
C-LTR
P8 9.4% 200 45% 0.24 0.15%
P10 4.9% 200 25% 1.25 0.77%
P11 1.4% 300 4% 0.99 0.35%
P12 2.4% 300 3% 2.38 0.97%
P13 14.7% 300 26% 4.16 1.54%
P14 7.8% 20 10% 0.29 1.25%
HIV seropositive individuals ranked from low CD4 count (P8) to high CD4 count (P14).
a Proviral copies per 106/ lymphocytes.
b Proportion to overall proviral load in PBMCs contributed by  lymphocytes.
c Contribution of CD4 lymphocytes to proviral load in  lymphocyte subset based on the mean contamination level of 0.21% (range 0.03%–0.46%,
n  3).
d Percentage of proviral load in  lymphocyte subset attributable to CD4 lymphocyte contamination.
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tion, we applied a newly developed method to score
phylogenetic trees, by calculation of an association in-
dex (AI) (Wang et al., 2001). AI scores ranging from 1.1086
to 0.5339 in three of the individuals indicated a complete
absence of cell type-specific segregation of V3 se-
quences (Fig. 3), while the value of 0.4932 for P10
showed only marginal separation, quite different from
previous comparisons of HIV recovered from different
autopsy tissues (Wang et al., 2001).
In vitro infection of  lymphocytes
To directly investigate the susceptibility of  lympho-
cytes to be infected with HIV, in vitro infectivity assays of
activated PBMCs were carried out using a laboratory
isolate of HIV-1 that expresses GFP, and therefore, al-
lows infection of each of the constituent lymphocyte
subsets to be monitored by flow cytometry (Figs. 4A–4E).
Following PHA activation, PBMCs isolated from healthy
donors were infected with stock virus derived from the
pNL4.3GFP clone at a multiplicity of infection of 0.1.
Following 5 days of culture, lymphocytes were stained
with different combinations of Mabs (CD4, CD8  chain,
CD8  chain, and  TCR) and analysed by flow cytom-
etry using the FL1/green channel to detect GFP expres-
sion. From this we were able to determine the frequen-
cies of infection of  lymphocytes expressing CD4 or
CD8, CD4 lymphocyte, and both CD4 and CD4 subsets
of CD8  lymphocytes (typical results for two combi-
nations of Mabs are shown in Figs. 4A and 4B).
Reproducible infection of each of the target lympho-
cyte subsets was found in the four PBMC samples sub-
jected to the infectivity assay (Figs. 4C–4E). Both CD8 
and  lymphocytes were susceptible to HIV infection
and showed frequencies of infection comparable or fre-
quently greater than found in CD4 lymphocytes. For ex-
ample, CD8 lymphocytes coexpressing CD4 [represent-
ing an activated phenotype (Imlach et al., 2001; Flamand
et al., 1998; Kitchen et al., 1998; Yang et al., 1998)]
showed a mean frequency of GFP-expression of 1.3-fold
higher that measured in CD4 lymphocytes. Remarkably,
 lymphocytes, particularly those expressing CD8 or
CD4, were even more susceptible to HIV infection, with
frequencies of GFP expression approximately 3- and
10-fold greater than found in CD4 lymphocytes.
To investigate the relationship between cell-surface
CD4 expression and susceptibility of  lymphocytes
and other subsets to infection, the effect of a blocking
anti-CD4 monoclonal antibody on the infectivity of each
lymphocyte subset was determined (Fig. 4D). As con-
trols, each experiment was carried out in parallel using
the reverse transcriptase inhibitor, AZT. At a concentra-
tion of 2.5 g/ml, frequencies of infection of each lym-
phocyte subset was reduced to generally less than 20%
of the untreated control level (Fig. 4E).
Each lymphocyte subset showed evidence for CD4-
418 IMLACH ET AL.
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dependence for virus entry. For example, pretreatment of
PBMCs with anti-CD4 antibody before infection reduced
the frequency of GFP-expressing  T lymphocytes ap-
proximately 12-fold in the CD4-expressing subset and by
8.5-fold in those expressing CD8. CD4-dependence on
entry of HIV into  lymphocytes was comparable to that
observed for the infection of CD4 and CD8 lymphocytes
(including those in the latter cell type without detectable
surface expression of CD4).
DISCUSSION
Surface phenotype of peripheral  lymphocytes
This study is the first to determine the effect of HIV
infection on the in vivo expression of the principal recep-
tors for HIV-1 CD4, CXCR4, and CCR5 on the surface of
peripheral  lymphocytes. In this lymphocyte subset,
expression of CCR5 was detected at substantial frequen-
cies in samples from HIV-uninfected individuals (mean,
62.7%) consistent with previous estimates (Glatzel et al.,
2002). The frequency of CCR5-expressing  lymphocyte
was reduced in the HIV-seropositive group (mean fre-
quency, 31.7%), possibly reflecting the previously ob-
served numerical decline in the frequency of the V9/
V2-expressing subset (Wallace et al., 1997; Poccia et al.,
1996), which expresses CCR5 (Glatzel et al., 2002). The
observed reduction in CCR5 expression may alterna-
tively or additionally be the result of the greater activation
of  lymphocytes in HIV infection (as manifested by up-
regulation of CD8); it has been previously observed that
physiological stimuli, such as extracts of Mycobacterium
tuberculosis, down-regulates CCR5 expression in  lym-
phocytes in vitro (Glatzel et al., 2002). These frequencies of
CCR5 expression contrast markedly to other lymphocyte
subsets, notably CD4 and CD8 lymphocytes in which CCR5
expression in vivo is generally associated with cellular
activation by antigenic stimuli (Wu et al., 1997).
The information gained on CD4 and chemokine recep-
tor expression on  lymphocytes provides additional
insights into the potential susceptibility of this to HIV
infection, as it is generally accepted from both in vitro
and in vivo studies that CD4 in association with either
CCR5 or CXCR4 is essential for HIV-1 to infect cells
(Dalgleish et al., 1984; Cloyd and Moore, 1990; Deng et
al., 1996; Dragic et al., 1996; Alkhatib et al., 1996; Berson
et al., 1996; Kozak et al., 1997; Feng et al., 1996). Clearly,
the expression of CD4, CCR5/CXCR4 and the pheno-
typically activated  lymphocytes renders this subset
potentially susceptible to productive HIV infection in vivo
by both R5 and X4-using variants of HIV-1, particularly
with the observed association between CD4 expression
and cellular activation (0.95% of CD4  lymphocyte
coexpressed CD8; Fig. 1H). Indeed, it is possible that the
observed reduction in frequency of CD4 and CCR5 ex-
pression in the  lymphocyte subset in HIV-seropositive
individuals (Fig. 2) reflects the specific targeting and
FIG. 2. Contribution to overall proviral load of CD4 lymphocytes (CD4), CD8 lymphocytes (CD8),  T lymphocytes (GD T cells) CD3 “Null”
cells, and non-T cells (expressed as a percentage contribution to the overall measured viral load) in peripheral blood samples from seven HIV
seropositive individuals. Seropositive individuals were ranked from low CD4 count (P8) to high CD4 count (P14). VL: circulating viral load (RNA copies
per millilitre of plasma).
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destruction of the CCR5 V9/V2 subset by HIV. Our
observations of HIV-infected  lymphocytes in the pe-
ripheral circulation, and their susceptibility to infection
with a laboratory isolate of HIV in vitro, clearly supports
this hypothesis (see below).
Susceptibility of peripherial  lymphocytes to HIV
infection
This study demonstrates for the first time HIV infection
of peripheral  lymphocytes in vivo. Although  lym-
phocytes represented between 1.4 and 14.7% of the cells
within the PBMC population, they represented between 3
and 45% of the proviral load detected when using C-LTR
primers (Table 1 and Fig. 2). An inherent problem of
immunomagnetic isolations is achieving a pure popula-
tion of cells, as contamination with another cell type
would alter proviral load measured by limiting dilution
PCR. Within this study, as in previous studies carried out
by our group (McBreen et al., 2001; Imlach et al., 2001),
calculation of the mean level of  TCR CD4 lympho-
FIG. 3. Phylogenetic analysis of V3 region from different lymphocyte subsets from four seropositive individuals ranked from low CD4 count (P8) to
high CD4 count (P14). Symbols:   CD3 CD4 lymphocytes, F   T lymphocytes. Trees were rooted using HIVSF162 sequence as an outgroup;
a scale bar is indicated at the bottom of each tree. Numbers at branches indicate bootstrap values greater than 70. AI: association index value
between CD3 CD4 lymphocyte V3 sequences and  T lymphocyte V3 sequences.
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cyte contamination within our isolated  lymphocyte
fractions combined with measurements of proviral loads
within this cell type indicated that CD4 lymphocyte con-
tamination (0.07–0.70% of the proviral load detecting us-
ing C-LTR primers; Table 1) could not account for the
proviral loads measured in  lymphocytes.
To provide more direct evidence for the susceptibility
and mechanism of  lymphocyte infection, we devel-
FIG. 4. Flow cytometric analysis of GFP expression in PHA-L-activated PBMC showing  T lymphocytes expressing CD4 (A) or CD8 (B). Forward-
and side-scatter plots highlighting the lymphocyte gate set on the PBMC sampled and dual parameter plot of CD4 and  TCR expression from the
R1 lymphocyte gate highlighting the  TCR CD4 gate (R2) and  TCR CD4 gate (R3) are shown in A. In B, the dual parameter plot of CD8 and
 TCR expression from the R1 lymphocyte gate highlighting the  TCR CD8 gate (R2),  TCR CD8 gate (R3), and  TCR CD8 gate (R4)
is shown. The CD8 gate used to select CD8,  cells was placed at 100 to exclude natural killer and activated CD4 lymphocytes (Sullivan et al.,
2001) from the analysis. Single-parameter histograms showing GFP expression in the gated lymphocytes from incubation with pNL4.3GFP alone,
treated with anti-CD4 antibody, and treated with AZT. A minimum of 100,000 cells in the R1 gate was collected. C–E, comparison of the levels of GFP
found in CD4 lymphocytes, CD8 CD4 lymphocytes, CD8 CD4 lymphocytes,  TCRCD4 lymphocytes,  TCRCD4 lymphocytes, 
TCRCD8 lymphocytes, and  TCRCD8 lymphocytes in PHA-L-activated PBMC cultures from HIV-seronegative individuals infected with
pNL4.3GFP HIV-1 for 5 days by flow cytometry (C) treated with anti-CD4 antibody (D) or treated with AZT (E). Results (mean  SD) were calculated
from four separate experiments.
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oped an in vitromodel of the entry and replication stages
of HIV infection using the NL4.3 HIV-1 isolate that ex-
presses GFP.  lymphocytes expressing CD4 were
found to be the phenotype most frequently infected by
HIV of all the lymphocyte subsets, with those expressing
CD8 the next highest (Fig. 3). Separate analysis of CD8
lymphocytes further indicated the substantial in vitro
susceptibility of cell with the CD8 CD4 double-posi-
tive phenotype as previously reported (Imlach et al.,
2001). Our observations of the exquisite susceptibility of
activated  lymphocytes to infection confirm and extend
the findings of SIV infection of this subset in vivo (Veazey
et al., 2000), and the previous report of in vitro productive
infection of cloned  T lymphocytes with the CXCR4-
utlising isolate, HIV-1LAI (Wallace et al., 1997). Pretreat-
ment with anti-CD4 antibody before addition of
pNL4.3GFP dramatically reduced the levels of GFP
levels detected in , CD4, and CD8 lymphocytes, sug-
gesting the major route of HIV-1 entry into  lympho-
cytes is mediated by CD4, and in the case of the isolate
used in the current study, by CXCR4. Commonality in the
mechanism of infection of  and CD4 lymphocytes in
vivo is provided by the evidence for genetic similarity
between variants infecting these two cell types in periph-
eral blood (Fig. 4). Indeed, the detection of HIV variants
with signature sequences characteristic of both X4- and
R5-utilizing variants of HIV (data not shown) in different
study subjects suggests some breadth in possible core-
ceptor usage of HIV infecting this cell type in vivo.
Interestingly, lower frequencies of in vitro infection
were also found in subsets of  and CD8 lymphocytes
that lacked detectable surface expression of CD4 and/or
FIG. 4.—Continued
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CD8. Although it is possible that such infections may
result from non-CD4-dependent mechanisms of entry,
the observation that infection of these subsets was also
inhibited by the anti-CD4 Mab (Fig. 3U) suggests alter-
native explanations. For example, it is possible that pro-
ductive infection led to the down-modulation of CD4 by
the action of Nef (Garcia and Miller, 1991).
Clinical significance of  lymphocytes infection
The significance of infection of  lymphocytes arises
first through the possibility that infection of this subset
contributes substantially to the reservoir of HIV-infected
cells in vivo, and second, that such infection leads to
measurable immune cell depletion and functional impair-
ment of mucosal defenses.
At this stage it is not possible to determine the con-
tribution of  lymphocyte infection to the reservoir of
HIV-infected cells. First, this study was dependent on
samples of peripheral blood as a source of  lympho-
cytes, and therefore, does not provide direct information
on the cell number, frequency of infection, or surface
phenotype of the likely much larger population resident
in mucosal tissues. A second unknown factor is how
labile the virus population is within  lymphocytes.
Without information on the turnover of infected cells of
this subset, it is difficult to predict the extent to which this
population would persist during antiretroviral therapy
and therefore contribute to the reactivation of virus rep-
lication during treatment cessation. Numerically,  lym-
phocytes represent a major cell type in adult gut tissue,
but there is evidence that their representation increases
in HIV infection, possibly by the homeostatic mecha-
nisms that increases their frequency in peripheral blood
(Nilssen et al., 1996). If the frequency of infection in gut
and lung-associated  lymphocytes was comparable to
that observed in peripheral blood, this cell type could
therefore harbour a substantial virus reservoir of infec-
tion.
The other potentially clinical relevant outcome of this
study is the possibility that infection of  lymphocytes
contributes to immunodeficiency, and in particular, the
host response to respiratory and gastrointestinal patho-
gens and neoplasia in which  lymphocytes are in-
volved. The mucosal element of the immune system fails
during infection with HIV-1, as highlighted by the devel-
opment of opportunistic diseases of the mucosal sur-
faces upon progression to AIDS. Whether  lymphocyte
infection and possible functional impairment or depletion
contributes to mucosal disease observed in AIDS is
controversial. The issue of whether  lymphocytes are a
significant contributor to mucosal immunity either di-
rectly through cytolytic activity and release of cytokines
or by suppressing the response of  TCR lympho-
cytes has yet to be properly address in humans (Hayday,
2000). For example, there is evidence that  lympho-
cytes may only play a significant role early in neonatal
development before the development of effective adap-
tive immune responses mediated by the  TCR lym-
phocytes and are redundant in the adult immune system
(Hayday, 2000). On the other hand,  lymphocytes have
been shown to have antiviral activity through direct lysis
of infected cells and release of HIV inhibitory chemo-
kines such as stromal cell derived factor 1 (Valenzuela-
Fernandez et al., 2001). Resolving this issue will be im-
portant in understanding the effect of HIV-induced de-
struction of this subset in HIV-infected individuals.
In the future, it will be necessary to determine whether
the extensive infection of  lymphocytes in the periph-
eral circulation is paralleled by infection of  lympho-
cytes in mucosal tissues lining the GI and respiratory
tracts. Similarly, to understand more about the potential
contribution of  lymphocytes to the virus reservoir,
investigation of sequential samples from individuals re-
ceiving HAART treatment will provide information on the
lability of this subset and its ability to persist during
periods of virus suppression. The findings obtained to
date do however indicate the possibility that HIV infec-
tion plays a direct aetiological role in impaired immune
defenses at mucosal surfaces, which should be consid-
ered in future investigations of HIV immunopathology
and in the development of mucosal vaccination strate-
gies.
MATERIALS AND METHODS
Samples and clinical details
Peripheral blood samples (20–30 ml) anticoagulated
with heparin sulphate were obtained by venipuncture
from 5 HIV-seronegative individuals and from 14 HIV-
seropositive individuals attending the Regional Infec-
tious Disease Unit, Western General Hospital, Edin-
burgh, U.K. Information about CD4 count, viral load,
duration of anti-viral therapy, and risk group for the HIV-
seropositive individuals is presented in Table 2.
Immunomagnetic T cell separation
Peripheral blood mononuclear cells were isolated
from whole blood by density centrifugation over Lym-
phoprep medium (Nycomed Pharma AS). T lymphocytes
were purified from PBMC samples via immunomagnatic
negative selection on an AutoMACS system using a
Pan-T cell isolation kit (Miltenyl Biotec) according to the
manufacturer’s instructions, with all solutions kept on ice
throughout the isolation procedure. Those cells retained
on the column (i.e., those cells expressing either CD11b,
CD16, CD19, CD36, or CD56) after the Pan-T cell isolation
had been carried out were eluted and referred to as
non-T cells.  T lymphocytes were isolated from purified
T lymphocytes by positive selection using a TCR 
microbead kit (Miltenyl Biotec). To the TCR -negative
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fraction, CD8 lymphocytes were isolated by positive
selection using CD8 microbeads (Miltenyl Biotec) and
CD4 lymphocytes were isolated from the TCR  neg-
ative fraction, CD8 negative fraction by positive selection
using CD4 microbeads (Miltenyl Biotec). Those cells that
remained (i.e., TCR  negative, CD8 negative, and CD4
negative) were retained and referred to as CD3 “Null”
cells.
Detection and quantitation of HIV sequences
DNA was extracted from selected cell subsets using
QIAamp DNA Mini kit (Qiagen Ltd., Crawley, U.K.). HIV
proviral sequences were quantified by limiting dilution
nested PCR using a nested set of highly conserved PCR
primers from the complete long terminal repeat (C-LTR)
and pan-LTR (P-LTR) amplified using previously de-
scribed primers and amplification conditions (Imlach et
al., 2001). Between 8 and 10 replicates at limiting dilution
were used for quantitation, providing an accuracy of
approximately 0.5 log10 in the estimation of proviral load
(Donaldson et al., 1994). Nucleotide sequences from the
V3 region (from study subjects P8, P9, P10, and P14)
were amplified using previously described primers and
amplification conditions (Kaufmann et al., 1998; Sanchez
et al., 1997; Simmonds et al., 1990a). PCR amplicons
were run at 150 V for 30 min on 2% w/v agarose gels
containing 0.5 g ethidium bromide per milliliter and
visualised under UV light. Quantification of the proviral
load in each of the selected cell subsets was performed
by limited dilution PCR as previously described (Sim-
monds et al., 1990b).
Nucleotide sequencing and analysis
Nucleotide sequences from the V3 region of the HIV-1
genome were amplified from single molecule DNA tem-
plates from P8, P9, P10, and P14 study subjects. Single
molecule V3 amplicons were isolated by limiting dilution
nested PCR and sequencing directly using ABI Prism
BigDye terminator cycle sequencing kit (Applied Biosys-
tems, Poster City, CA) following the manufacturer’s in-
structions. Briefly, V3 amplicons were purified before
sequencing using QiAquick PCR purification kit (Qiagen).
The sequencing reaction consisted of approximately 10
ng of secondary V3 amplicon, 3.2 pmol of V3 inner sense
primer, 8 l terminator ready reaction mix, and deionized
nuclease-free water up to a total volume of 20 l. Se-
quencing reactions were carried out using the following
parameters: 96°C for 30 s, 50°C for 15 s, and 60°C for 4
min for 25 cycles at a thermal ramp rate of approximately
1°C/s, followed by a thermal ramp to 4°C and held until
the products were ready to be purified. Amplicons were
purified before sequencing using QiAquick PCR purifica-
tion kit (Qiagen) and the products run on an ABI Prism
3100 genetic analyser. Returned sequence files were
checked using Chromas 1.45 and imported into and
aligned using the Simmonic 2000 sequence editor pack-
age. Phylogenetic trees were constructed by neighbour-
joining using Jukes–Cantor corrected sequence dis-
tances in the MEGA 2.1 package. The degree of genetic
segregation of V3 sequences recovered from difference
cell types within the same patient was scored by an
association index as previously described (Wang et al.,
2001). Nucleotide sequences obtained during the study
TABLE 2
Clinical Profile of HIV-Seropositive Study Subjects
Study
subject Sexa Age Risk groupb CD4 count/l Viral load/l
Duration of
therapy (months)
P1 F 41 IVDU 25 109,000 NTc
P2 F 40 IVDU 104 14,800 NT
P3 M 37 MSM 252 1030 3
P4 F 35 IVDU 334 139,000 NT
P5 M 64 NI 334 400 7
P6 M 37 MSM 430 20,500 NT
P7 F 41 WSM 546 50 33
P8 M 53 IVDU 35 83,100 24
P9 F 35 WSM 87 750,000 2
P10 F 43 WSM 207 105,000 12
P11 F 38 WSM 236 101 14
P12 F 33 WSM 399 50 25
P13 M 44 IVDU 713 41,400 NT
P14 M 41 IVDU 826 50 12
a F, female; M, male.
b Risk groups, IVDU  intravenous drug abuser, MSM  men who have sex with men, WSM  women who have sex with men, NI  needlestick
injury.
c No therapy.
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have been submitted to GenBank and have been as-
signed the accession numbers AY 171414–AY 171559.
Peripheral blood mononuclear cell isolation and
culture
PBMCs were isolated from approximately 40–50 ml
whole blood from HIV-seronegative individuals by den-
sity centrifugation over Lymphoprep medium (Nycomed
Pharma AS). Isolated PBMCs were counted using a hae-
mocytometer and the cell concentration adjusted to 1 
106 PBMCs/ml in RPMI 1640 medium containing 10% v/v
foetal calf serum, 2 mM L-glutamine, 100 IU/ml penicillin
with 100 g streptomycin (RF10 medium) and activated
using phytohemagglutinin-L (PHA-L) at 5 g/ml (Sigma,
Poole, U.K.). Cells were placed into culture for 72 h at
37°C and 5% CO2 atmosphere before infection with
HIV-1.
Infection of PHA-L-activated PBMC cultures with HIV-1
Infection assays of different lymphocyte subsets in
PBMCs were carried out using a green fluorescent pro-
tein (GFP)-expressing HIV isolate derived from the
pNL4.3GFP molecular clone of a CXCR4-utilising sub-
type B laboratory strain of HIV-1 (Welker et al., 1996).
PHA-L activated PBMC cultures were pelleted by centrif-
ugation and resuspended in 500 l of RF10 medium and
2 ml of cell-free culture supernatant of pNL4.3GFP
HIV-1 isolate and incubated for 2 h at 37°C. PBMCs were
pelleted by centrifugation and resuspended in RF10 me-
dium at a concentration of 1  106 PBMC/ml containing
20 IU recombinant interleukin 2/ml (rIL-2, ARP901, ADP,
NIBSC, Potters Bar, U.K.) and cultured for 4 days at 37°C.
Virus replication and entry was inhibited in control cul-
tures through the use of anti-CD4 antibodies or zidovi-
dine (AZT). Briefly, before infection with HIV-1, 1  107
PBMC were centrifuged and resuspended in 500 l of
RF10 and treated with either 100 g anti-CD4 antibody
(ARP318, ADP, NIBSC) or 50 g AZT (ARP952, ADP,
NIBSC) for 30 min at 4°C. After incubation, HIV-1 was
added to the treated cells as above and incubated for 2 h
at 37°C. The virus was removed by centrifugation and
the PBMCs were resuspended in RF10 medium contain-
ing 20 IU rIL-2/ml and either 2 g anti-CD4 antibody/ml
or 2.5 g AZT/ml and analysed by flow cytometry after 5
days in culture.
Flow cytometric analysis of GFP expression in
pNL4.3GFP HIV-1-infected PBMC
Flow cytometric analysis was carried out on a FACS-
Calibur flow cytometer (Becton–Dickinson, Crawley, U.K.)
by gating on lymphocytes based on their forward- and
side-scatter characteristics, with a minimum of 100,000
events collected. Monoclonal antibodies and isotype-
matched mouse immunoglobulin controls [labelled with
phycoerythrin (PE), PE-Cy5 (Cy5), and fluorescein iso-
thiocyanate isomer 1 (FITC)] to the following cell-surface
markers were obtained: CD4-Cy5 (clone MT310, Dako,
Ely, U.K.), CD8 -chain-PE (clone 2ST8.5H7, Coulter Im-
munotech, High Wycombe, U.K.), and  TCR-PE (clone
11F2, BD Biosciences, Cowly, U.K.). Approximately 2 
106 infected PBMCs were resuspended in 200 l PBS
containing 1% w/v bovine serum albumin (BSA)  2 mM
ethylenediaminetetraacetic acid (EDTA). The appropriate
antibodies were added at the manufacturers’ recom-
mended concentration and incubated at 4°C for 30 min.
Cells were washed twice with PBS containing 1% w/v
BSA  2 mM EDTA before fixation in PBS containing 2%
w/v paraformaldehyde for 1 h at 4°C prior to flow cyto-
metric analysis.
To accommodate day-to-day variation in the infectivity
assays associated with the use of different PBMC prep-
arations and virus stocks, frequencies of infection of
different lymphocytes were expressed as ratios to those
recorded for CD4 lymphocytes in each culture. Typically
between 0.35 and 0.99% (mean, 0.55%, n  4) of the CD4
lymphocytes were productively infected over the 5-day
culture, as measured by levels of GFP by flow cytometry.
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